Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday ...

Ozzy Osbourne will come out of touring retirement and reunite with the full Black Sabbath lineup for the first time in 20 ...

The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's ...

Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease.

The world-renowned Israeli-Argentine pianist and conductor Daniel Barenboim revealed Thursday he is suffering from ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The Parkinson’s Foundation estimates that 15,000 people here in Wisconsin have Parkinson’s disease, and that number is only ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

In a groundbreaking development for neurological care, scientists have unveiled an artificial intelligence-powered blood test that has the potential to detect Parkinson’s disease years before ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...